Marilyn E. Wortzman

2011

In 2011, Marilyn E. Wortzman earned a total compensation of $676.8K as Vice President, Finance at Paratek Pharmaceuticals, a 42% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$73,500
Option Awards$361,758
Salary$241,508
Total$676,766

Wortzman received $361.8K in option awards, accounting for 53% of the total pay in 2011.

Wortzman also received $73.5K in non-equity incentive plan and $241.5K in salary.

Rankings

In 2011, Marilyn E. Wortzman's compensation ranked 7,069th out of 10,747 executives tracked by ExecPay. In other words, Wortzman earned more than 34.2% of executives.

ClassificationRankingPercentile
All
7,069
out of 10,747
34th
Division
Manufacturing
2,584
out of 3,960
35th
Major group
Chemicals And Allied Products
624
out of 1,038
40th
Industry group
Drugs
427
out of 786
46th
Industry
Pharmaceutical Preparations
331
out of 571
42nd
Source: SEC filing on April 24, 2012.

Wortzman's colleagues

We found four more compensation records of executives who worked with Marilyn E. Wortzman at Paratek Pharmaceuticals in 2011.

2011

Glenn Oclassen

Paratek Pharmaceuticals

Chief Executive Officer

2011

Nikhilesh Singh

Paratek Pharmaceuticals

Chief Scientific Officer

2011

Thomas Soloway

Paratek Pharmaceuticals

Chief Financial Officer

2011

Joseph Kennedy

Paratek Pharmaceuticals

General Counsel

In-depth

You may also like